this post was submitted on 09 Sep 2023
88 points (100.0% liked)
U.S. News
2241 readers
88 users here now
News about and pertaining to the United States and its people.
Please read what's functionally the mission statement before posting for the first time. We have a narrower definition of news than you might be accustomed to.
Guidelines for submissions:
- Post the original source of information as the link.
- If there is a paywall, provide an archive link in the body.
- Post using the original headline; edits for clarity (as in providing crucial info a clickbait hed omits) are fine.
- Social media is not a news source.
For World News, see the News community.
This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.
founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
JFC. There's an opioid shortage too and for the same apparent reason: the federal government setting limits on manufacturers.
I have cancer and have been on oxycodone daily for many months now. Last time I needed a refill, I almost couldn't get any in time before running out. Got it literally the night I took my last one. Can you imagine dealing with cancer pain AND opioid withdrawal symptoms at the same time? Why should I have to deal with that?
And why should all the families dealing with ADHD have to deal with shortages of drugs to treat that? This whole situation is fucking absurd.
I don't know much about the opioid shortage, but for Adderall it seems to be more complicated than just the quotas.... https://www.bloomberg.com/news/newsletters/2023-02-28/are-adderall-dea-quotas-contributing-to-the-shortage
If a manufacturer asks for an increased quota and the DEA denies it, they have to do so publicly, with a notice. Guess what, no notices.
Another source:
https://www.livemint.com/news/world/whats-behind-shortages-of-adderall-ozempic-and-other-meds-in-us-11682897998433.html
And another https://www.painnewsnetwork.org/stories/2023/8/3/fda-and-dea-leaders-call-for-more-adhd-meds-but-ignore-rx-opioid-shortages